Resources for Researchers

NIAID offers many resources to support your research, including reagents, model organisms, and tissue samples, to name just a few. Use the filters under Filter Search Results to narrow your search, or simply enter specific search terms in the search field.

We found 9 resources that match your search and filter choices.

Your selections:
Clear all

Show Filters

  • NIH AIDS Reagent Program

    The National Institutes of Health (NIH) AIDS Reagent Program provides critical research reagents and resources to the scientific community. The ARP acquires, develops, and produces state-of-the-art reagents and provides these reagents at no cost to qualified investigators throughout the world. The...

    coanstevensje@nih.gov - 2017-08-28 15:27

  • HIV Drug Formulation Development and Manufacturing Services

    This service program supports the development and manufacture, of a wide variety of pharmaceutical dosage formulations, including tablets, capsules, semi-solid preparations, injectibles, and sustained-release products. If requested, manufacturing can be done under GMP....

    coanstevensje@nih.gov - 2017-08-28 15:27

  • HIV/TB Drug Development: Chemical Synthesis

    This service provides chemical synthesis of lead compounds for use in additional drug development studies. Compounds must previously have been successfully synthesized to be candidates for this service. Synthesis of new analogs is not supported....

    coanstevensje@nih.gov - 2017-08-28 15:27

  • HIV Drug Development: Analytical Chemistry Services

    This service can be used to develop and perform a variety of analytical assays to assess the properties of drug substances and their formulations....

    coanstevensje@nih.gov - 2017-08-28 15:27

  • ACTG Network Laboratory (ACTG NL)

    The ACTG NL consists of Core Laboratory groups in immunology, pharmacology, virology and TB. Each Core Laboratory Group is comprised of several Specialty Laboratories that provide a broad range of assays and services required to conduct the scientific agenda of the ACTG and to complement laboratory...

    coanstevensje@nih.gov - 2017-08-29 17:42

  • Phase I Clinical Trial Units for Therapeutics

    The Phase I Clinical Trial Units for Therapeutics support the design, development, implementation, and conduct of Phase I clinical trials to assess safety, pharmacokinetics, and/or pharmacodynamics of licensed and investigational therapeutic products, including immunomodulatory agents and monoclonal...

    coanstevensje@nih.gov - 2017-08-30 19:13

  • Vaccine and Treatment Evaluation Units (VTEUs) Services

    The Vaccine and Treatment Evaluation Units (VTEUs), supported by the Division of Microbiology and Infectious Diseases (DMID) since the 1960s, comprise a consortium of contracts with academic centers and organizations that provides a ready resource for the conduct of clinical trials to evaluate...

    coanstevensje@nih.gov - 2017-09-08 14:17

  • Resources to Evaluate New Technologies for Monitoring HIV-infected Patients

    Current methods for monitoring HIV-infected patients on antiretroviral therapy are expensive and technologically complex, making it difficult for use in resource-limited countries around the world. To advance the field, NIAID has resources available to assist investigators who wish to evaluate new...

    coanstevensje@nih.gov - 2017-09-27 13:04

  • Microbicide Trials Network (MTN) Resources

    The Microbicide Trials Network (MTN) is a NIAID-funded worldwide collaborative clinical trials network focused on preventing the sexual transmission of HIV. The MTN accepts concepts for new protocols, ancillary study proposals, secondary data analysis requests, and dataset requests....

    coanstevensje@nih.gov - 2017-09-27 14:05